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Jaagsiekte sheep retrovirus (JSRV) is the causative agent of ovine pulmonary adenocarcinoma (OPA). In this study, we followed over
a 31-month period the natural transmission of JSRV in adult sheep and in their offspring. We established groups derived from flocks with
either a high or low incidence of OPA and monitored virus transmission, clinical disease and macroscopic/microscopic lung lesions at
necropsy. Results obtained show that (i) JSRV infection can occur perinatally or in the first few months of life in lambs and in adult
sheep; (ii) only a minority of JSRV-infected animals develop clinical disease during their commercial lifespan; and (iii) JSRV is more
readily detectable in peripheral blood leucocytes and lymphoid organs than in the lungs. These data support a model of opportunistic
JSRV infection and tumorigenic conversion of type II pneumocytes/Clara cells in the lungs, while lymphoreticular cells serve as the
principal virus reservoir.
D 2005 Elsevier Inc. All rights reserved.Keywords: Ovine pulmonary adenocarcinoma; OPA; Jaagsiekte sheep retrovirus; JSRV; JSRV transmission; Retroviruses; Retrovirus pathogenesis; SheepIntroduction
Ovine pulmonary adenocarcinoma (OPA) is one of the
major infectious diseases of sheep in many regions of the
world and is considered a large animal model for lung
carcinogenesis (Fan et al., 2003; Palmarini and Fan, 2001;
Palmarini et al., 1997). OPA is caused by a retrovirus known
as Jaagsiekte sheep retrovirus (JSRV) (DeMartini et al.,
2001; Palmarini et al., 1999). The disease is clinically
characterised by a chronic respiratory syndrome resulting
from the development of lung adenocarcinoma and often
secondary bacterial infections (Sharp and DeMartini, 2003).0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.05.018
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E-mail address: m.palmarini@vet.gla.ac.uk (M. Palmarini).In OPA-affected sheep, JSRV antigens are readily
detectable by immunohistochemistry or ELISA only in lung
tumour cells and in lung secretions (Flung fluid_) that
accumulate in the airways of most animals with classical
clinical signs. The neoplasm originates from type II
pneumocytes and Clara cells of the lungs of OPA sheep
(De las Heras et al., 2003; Palmarini and Fan, 2001;
Palmarini et al., 1995, 1996a, 1997; Platt et al., 2002).
Interestingly, by immunohistochemistry, normal type II
pneumocytes or Clara cells surrounding the tumour in
OPA lesions do not show JSRV antigens. In OPA-affected
sheep, JSRV is also detectable in cells of the lymphor-
eticular system, but only by employing highly sensitive
PCR assays (Gonzalez et al., 2001; Holland et al., 1999;
Palmarini et al., 1996b); only occasionally, lymphoid cells
were revealed to contain JSRV antigens by immunohisto-05) 144 – 153
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tumours (Holland et al., 1999). Thus, the target cells for
JSRV-induced cell transformation are also those that appear
to produce the greatest amount of virus.
The incidence of clinical disease in an affected flock is
generally around 2–5% with most of the clinical cases
occurring in sheep between 2 and 4 years of age (Sharp and
DeMartini, 2003).
JSRV is unique among oncogenic retroviruses as its
envelope protein (Env) behaves in vitro as a dominant
oncoprotein (Allen et al., 2002; Maeda et al., 2001; Rai et
al., 2001). In addition, mice inoculated with an adeno-
associated virus vector expressing the JSRV Env developed
OPA-like lesions in as little as 8 weeks (Wootton et al.,
2005). Thus, JSRV behaves essentially as a rapidly trans-
forming retrovirus in vitro, in the experimental lamb model
in vivo and in an experimental mouse model. However, the
disease is believed to have a very long incubation period in
naturally occurring OPA (Sharp and DeMartini, 2003).
Indeed, OPA was included, along with scrapie, para-
tuberculosis and Maedi-Visna, among the Fslow_ diseases
of sheep originally described by Sigurdsson in Iceland in
the 1950s (Sigurdsson, 1954, 1958). In old transmission
studies using adult sheep, OPA was reproduced after an
incubation period of several months to years (Dungal,
1946). However, the disease is reproducible in as little as 3
to 4 weeks when concentrated lung secretions from an
affected animal are inoculated into neonatal new-born
lambs (Salvatori et al., 2004; Sharp et al., 1983; Verwoerd
et al., 1980).
The majority of virus transmission studies in the JSRV/
OPA system have been done using the experimental lamb
model. Data on the natural transmission of JSRV-infection
are scarce. The difficulty of monitoring virus transmission
studies in the JSRV/OPA system is due to the combination
of two factors: sheep infected with JSRV (with or without
clinical disease) do not show a detectable immune response
towards the virus (Ortin et al., 1998; Spencer et al., 2003;
Summers et al., 2002) and a very low proviral burden is
present in the blood of infected animals (Gonzalez et al.,
2001; Holland et al., 1999; Palmarini et al., 1996b). Sheep
are probably immunotolerant to JSRV due to the expression
of JSRV-related endogenous retroviruses during fetal
development (Spencer et al., 2003). Only very sensitive
PCR assays, based on the described hemi-nested LTR PCR
(hnLTR-PCR) on PBLs of infected animals, can be
employed to detect JSRV during the pre-clinical stages of
OPA (Palmarini et al., 1996b). To increase the sensitivity of
the assays, various investigators have modified the assay
above by employing more than 5 or 6 replicates of DNA
(¨500 ng each) per sample (Gonzalez et al., 2001; Holland
et al., 1999). A single step LTR-PCR using three replicates
of genomic DNA has also been used with comparable
sensitivity (Salvatori et al., 2004) although in our hands the
hnLTR-PCR is more sensitive than a single step PCR assay
(results not shown; De las Heras et al., in press).In this study, the objectives were to follow (i) the natural
transmission of JSRV infection, (ii) development of clinical
disease and (iii) histopathological lesions in adult sheep and
their offspring over a 31-month period. Our data indicate
that JSRV infection can spread readily both in lambs and
adult animals but that the onset of clinical disease and tumor
lesions during the commercial lifespan of sheep occurs in a
minority of JSRV-infected animals after a long incubation
period. This study introduces new concepts in the patho-
genesis of OPA.Results
Sensitivity and specificity of the PCR procedure used in this
study
In this study, we followed the natural transmission of
JSRV infection and clinical/histopathological lesions among
adult sheep and lambs. We used the hnLTR-PCR already
described (Gonzalez et al., 2001; Holland et al., 1999;
Palmarini et al., 1996b) to detect JSRV in PBLs, mediastinal
lymph nodes, spleen and lungs of sheep and used three
replicates of 500 ng of DNA per sample to reach an optimal
compromise between sensitivity (e.g., the probability to
detect a JSRV-infected animal) and specificity (e.g., the
probability that a sample tested positive is not a false positive)
of the test given the high numbers of samples analysed.
The sensitivity and specificity of a single hnLTR-PCR
reaction to detect JSRV in PBLs of a JSRV-infected sheep
depends on the number of replicates performed in each
single test. Within a single replicate per sample, the hnLTR-
PCR sensitivity is 6.1% and specificity is 99.4% (see also
Materials and methods). With 3 replicates in a single test,
the theoretical sensitivity is 17.5% (the observed one was
16.2%) and the theoretical specificity is 98.3% (the
observed one was 98.8%).
Sensitivity and specificity of the entire procedure
based on repeated testing of the same animal depends
on both the number of replicates performed in each test
and on the number of repeated tests performed on the
same animal. Thus, a minimal acceptable value for the
sensitivity (i.e., around 50–60%) would result from 4 to
5 repeated tests with 3 replicates per each test. The
specificity corresponding to these sensitivity values is
between 91% and 93%. Given the difficulty in defining
with certainty an OPA-free flock in this study, case and
control animal definitions were designed to be as
conservative as possible.
Given the high level of sensitivity of the PCR test
(Holland et al., 1999; Palmarini et al., 1996b), great care
was taken to avoid, and control for, PCR contaminations.
We tested a total of 835 intercalated extractions and DNA
controls for a total of 1106 samples, excluding the common
reaction mixture controls included in each PCR reaction (see
also Materials and methods).
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lambs and adult sheep
Initially, we tested peripheral blood leucocytes (PBLs)
from sheep of a commercial flock that in recent years had
2–3% annual mortality due to OPA. In a single hnLTR-PCR
test performed on PBLs, 14 sheep tested positive out of 220
sheep in the flock. In this study, the time of blood collection
in the commercial flock was designated as time 0. The
experimental timeline is summarised in Fig. 1. Thirteen of
the 14 JSRV PCR positive sheep were purchased and
constituted ewes of Group A (high incidence of OPA
infection) of our experiment. A group of 22 ewes derived
from a flock with no recent history of OPA disease and
which tested negative in two subsequent PCR assays
constituted our group of low incidence of OPA-infection
(Group B). Group B ewes were housed separately from
Group A. Given the low level infection of PBLs of JSRV-
infected animals, it was not possible to establish an OPA-
free flock with certainty. Six of the 22 ewes originally
constituting Group B were housed with Group A and
formed Group AB. This group of animals served to
determine if JSRV infection could be established among
adults.
Once the groups were established (time 8 months), PBLs
were collected between 9 and 12 times in the subsequent two
years from the adult sheep. Lambing occurred at 15 months
(first crop) and 26 months (second crop). PBLs in the first
crop were tested 3 to 9 times in 16 months (average = 7.04),
while PBLs of the second crop were tested 5 times with the
exception of lamb 91 which was tested only twice.
At 31 months, all adults of Groups A (n = 13), B (n = 16)
and AB (n = 6) as well as the lambs of the first crop (16
months of age; n = 12 for Group A; n = 5 for Group B; and
n = 4 for Group AB) were euthanised. The experiment was
terminated when the lambs of the second crop (n = 12 for
Group A; n = 8 for Group B and n = 8 for Group AB)
reached 5 months of age; they were not euthanised and,Fig. 1. Timeline of this study. Time 0 was taken when the sampling of the
commercial flock was originally performed. The end of the study (time 31
months) is at the post-mortem examination performed on adults and the first
crop of lambs of Groups A, B and AB.consequently, samples from internal organ from these
animals were not tested.
The distribution of JSRV infection among the various
groups and the statistical significance of the differences
obtained is summarised in Table 1, while Fig. 2 summarises
the tests and the results obtained in each individual animal.
We defined an animal infected with JSRV as a sheep that
had at least one positive PCR reaction in the samples
examined. In total, 29/37 (78%) sheep of Group A, 12/18
(66.6%) of Group AB and 3/29 (10%) for Group B had at
least one PCR-positive reaction in PBLs during the duration
of the experiment and/or in spleen, lymph nodes and lungs
at the end of the experiment. Differences observed are
statistically significant and are also indicated in Table 1.
Thus, JSRV infection was able to spread between adults and
lambs.
Among the lambs of the first crop, 11/12 and 3/4 became
positive in Groups A and AB, respectively. None of 5
became positive among lambs of Group B. Among the
lambs of the second crop, 5/12 became positive for JSRV
infection in Group A, 4/8 in Group AB and 0/8 in Group B.
More than half (13/23) of the lambs that tested positive
for JSRVat least once were so within the first 3 months after
birth (Fig. 3). On the other hand, only 1 of the five adults of
Group AB tested positive for JSRV within the first 7 months
after being housed with the animals of Group A. Thus,
lambs might be more receptive to JSRV infection or perhaps
be exposed more easily to JSRV infection than adults.
Seven lambs tested positive by PCR the first day after
birth, and four of them were positive in at least one other
PCR assay in subsequent tests. This result suggests that
JSRV (or JSRV-infected cells) might be transmitted through
the milk, or blood/placental-infected tissues at delivery, via
the close mother-lamb contact immediately after birth, or in
utero. However, we also tested by hnLTR-PCR, PBLs and
lungs of 20 foetuses collected by Caesarean section from
ewes between 4 and 5 months of gestation (gestation in
sheep is 150 days). All the fetuses were derived from ewes
of Groups A and AB but none of the samples (n = 40) were
positive. The difference between the 0/40 JSRV positive
PCRs in foetuses versus the 7/36 positive PCRs in PBLs
collected from lambs of Groups A and AB at day 1 is
slightly above statistical significance (P = 0.058).
The data presented here suggest that both adults and
lambs are susceptible to JSRV infection under natural
conditions. Most of the lambs were JSRV PCR positive
very rapidly after birth suggesting that perinatal infection
could be a significant route of transmission. Further, no
evidence of intrauterine transmission of JSRV was found,
albeit our studies cannot exclude this possibility.
Only a minority of JSRV-infected sheep develop tumour
lesions during their commercial lifespan
Of the 13 adult animals of Group A only one (sheep
number 7) developed clinical signs of OPA. The affected
Table 1
Distribution of JSRV infection in this study
No. of infected animals/no. of tested animals (% infected)
Animals Group A Group AB Group B Fisher’s P
Adults 13/13
(100%)
5/6
(83.3%)
3/16
(18.7%)
A vs. B P < 0.01
AB vs. B P = 0.01
Lambs
1st crop
11/12
(91.6%)
3/4
(75%)
0/5
(0%)
A vs. B P < 0.01
AB vs. B P = 0.015
Lambs
2nd crop
5/12
(41.6%)
4/8
(50%)
0/8
(0%)
A vs. B P = 0.1
AB vs. B P = 0.02
Total 29/37
(78%)
12/18
(66.6%)
3/29
(10.3%)
A vs. B P < 0.01
AB vs. B P < 0.01
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the beginning of this study. Diagnosis was confirmed by
histopathology. To our knowledge, this is the first non-
anecdotical report demonstrating that OPA can have an
incubation period of several years. Two sheep (numbers 3
and 31) showed no clinical signs of OPA, but histological
examination of the lungs revealed proliferation of epithelial
cells in the alveoli (Fig. 4) consistent with early OPAFig. 2. Schematization of the results obtained in individual animals. The key for the
circles indicating lambs of the 1st and 2nd crop have been put directly below circlesions, which were subsequently confirmed by immuno-
histochemistry to contain JSRV antigens (see below). The
average age of the ewes was 4.5 years and consequently at
the end of the experiment the ewes of Group A were 7–8
years of age which is beyond the usual age that sheep are
kept in most commercial enterprises. Thus, it appears that
most JSRV-infected sheep do not develop clinical signs or
even tumour lesions during their commercial lifespan. The
2–5% incidence of mortality in OPA-affected flocks might
reflect a much higher rate of infection. The apparent
prevalence of OPA infection in the commercial flock that
were a source of Group A ewes was 6%, using a single
hnLTR-PCR assay. However, due to the low sensitivity of
the test, the true prevalence of infection in the flock of origin
is higher than the observed value. Mathematical modeling
would predict that the prevalence of OPA infection in the
commercial flock utilised in the study was actually 34.5%,
within the range 18.2%–60.5% with 95% probability. Thus,
the incidence of JSRV infection in an affected flock is likely
much higher than previously believed.interpretation of colours and numbers is shown within the figure. Note that
les representing the respective mothers.
Fig. 3. Results of PCR assays in JSRV-infected lambs (Groups A and AB)
and adults (Group AB) in relationship to the time after birth or potential
exposure to infection. Note that the figure represents only infected lambs
(23 of 36 for Groups A and AB and 0/13 for Group B) and adults (5/6 of
Group AB). Samples tested positive are indicated by solid shapes; empty
shapes represent samples tested negative.
M. Caporale et al. / Virology 338 (2005) 144–153148Lower than expected levels of JSRV-infection in the lungs of
OPA-infected animals
By PCR, we found evidence of JSRV provirus in the
lungs of only 8 of 56 sheep in which a post-mortem
examination was performed (e.g., adults and lambs of the
first crop). By contrast, 35 of these 56 sheep had evidence of
JSRV provirus in PBLs or lymphoid organs such as spleen
and mediastinal lymph nodes. It should be noted that we
tested by PCR DNA collected from 7 anatomical regions of
the lungs in 25 of 35 animals that underwent post-mortem
examination for Groups A and AB and in all (n = 21) of the
animals of Group B. Thus, among the adults of Group A (the
only animals known to be infected by JSRVat the beginning
of the study) positive PCR reactions were obtained in 42 of
144 PBLs/lymphoid organ samples, whereas only 4 of 80lung samples were positive. The noted differences are
statistically significant (P < 0.001 by chi-squared test) and
support the hypothesis that during the natural course of
infection, cells of the lymphoreticular system can be the only
cells infected by JSRV. The target cells of JSRV trans-
formation, type II pneumocytes and Clara cells, might be
infected only at a later time if they become infected at all (see
also Discussion). In the lung samples containing early OPA
lesions (sheep numbers 3 and 31), we found also JSRV
proviral DNA in the analogous lung tissue by PCR. We did
not find the presence of provirus in the other 6 anatomical
regions of sheep 31 (for sheep number 3, we collected only 2
portions of lungs with one being PCR negative). By
immunohistochemistry, we detected JSRV antigens only in
corresponding neoplastic lesions or early lesions (Fig. 4).
However, JSRVantigens were not detected in the neighbour-
ing epithelial cells, as already observed in advanced lesions
(Palmarini et al., 1995; Platt et al., 2002).
As mentioned above, 8 lung samples were positive by
PCR, but in only three cases, there were OPA tumour
lesions and these were also positive by immunohistochem-
istry; in the other 5 cases, no cells reacted positively to anti-
JSRV Gag or Env antisera by immunohistochemistry.
Interestingly, in 6 of 8 cases, the PCR-positive reactions
in the lungs were derived from samples collected from the
cranial and accessory lobes (Fig. 4A), suggesting infection
originated via the aerogen route.Discussion
In this study, we followed the natural transmission of
JSRV infection, onset of neoplastic lesions and development
of clinical disease among adult and young sheep over a
period of 2 and half years. This is the first longitudinal study
to examine the natural transmission of JSRV infection. Our
data show that: (i) JSRV can establish infection very readily
(even perinatally) in young lambs; (ii) adult sheep can be
infected horizontally; (iii) the majority of infected animals
do not show clinical disease during their commercial
lifespan; and (iii) JSRV infection is, in general, more readily
detectable in peripheral blood leucocytes (PBLs) and
lymphoid organs than in the lungs. In addition, this study
also firmly establishes that the incubation period in naturally
occurring OPA can be of several years in duration.
Our data have several implications for understanding the
pathogenesis of OPA and the evolution of JSRV. JSRV was
inferred to be a lung-tropic retrovirus that replicates
preferentially in the target cells for transformation. First,
high level JSRV expression is detectable only in the
transformed type II pneumocytes/Clara cells of OPA-
affected animals (Palmarini et al., 1995; Platt et al., 2002)
where the virus can be demonstrated using immunoassays
such as ELISAs, Western blotting or immunohistochemistry.
In contrast, JSRV can be detected in lymphoid cells and
organs only using highly sensitive PCR assays (Garcia-Goti
Fig. 4. JSRV infection in the lungs. (A) For most of the lungs tested (45/56), tissues were sampled for PCR, histopathology and immunohistochemistry in 7
anatomical regions indicated by the black circles. In one case, only 2 of the 7 regions were available for analysis. In 10 cases, it was not possible to determine
the exact region in the lungs where the samples originated—PCR results from these samples are not included in the figure shown. Numbers above the circles
indicate the number of positive hnLTR-PCRs out of the total number of samples examined for each area. Panels B–D show immunohistochemistry on
advanced lesions from sheep number 31 (panel B, Scale bar = 100 Am) and early histological lesions from the lungs of sheep number 3 (panels C and D; Scale
bar = 25 Am). Brown staining represent positive reaction and is confined in the epithelial transformed cells.
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Palmarini et al., 1996b; Salvatori et al., 2004). Further, we
found that the long terminal repeats of JSRV are specifically
active in type II pneumocytes and Clara cells in vitro and
interact with lung-specific transcription factors such as
HNF-3h (McGee-Estrada et al., 2002; Palmarini et al.,
2000).
However, in this study, JSRV was detected more easily in
lymphoid cells and organs rather than in the lungs of
naturally infected sheep during the pre-clinical stages of
OPA and before onset of histopathological alterations. Only
a minority of adult JSRV-infected sheep (3 of 16) developed
lung adenocarcinoma over a 31-month period, and by the
end of the experiment, most of the sheep had already
reached the end of their commercial lifespan. Thus, in an
affected flock the clinical cases of OPA are most likely only
the Ftip of the iceberg_ with respect to the JSRV-infected
animals. Our results are supported by an unrelated longi-
tudinal study performed in a commercial flock where only
5%–6% of sheep that tested positive to JSRV by PCR in
PBLs developed OPA (De las Heras, unpublished).
The envelope of JSRV functions essentially as a
dominant oncogene. A variety of cell lines can be trans-
formed by transfection of expression plasmids encoding the
JSRV Env (Allen et al., 2002; Maeda et al., 2001; Rai et al.,
2001). Thus, JSRV is a replication-competent retrovirus thatcan function as an acutely transforming retrovirus. Indeed,
the incubation period of OPA is only a few weeks or months
in new-born lambs following experimental intratracheal
infection of concentrated lung secretions from OPA-affected
sheep or with a JSRV molecular clone (Palmarini et al.,
1999; Sharp et al., 1983; Verwoerd et al., 1980). In addition,
lung adenocarcinoma was reproduced in immunodeficient
mice inoculated with adenovirus-associated virus vectors
expressing the JSRV envelope (Wootton et al., 2005).
However, an apparent conflict with these observations
exists because the incubation period of OPA in nature can
be of several months/years as suspected in older studies
(Sigurdsson, 1954, 1958) and firmly proved in the present
one.
The discrepancy between the incubation period in
experimentally-induced and naturally occurring OPA may
be due to experimental exposure of lambs to a much higher
amount of virus and/or to higher susceptibility of target cells
to infection by JSRV in young lambs. It is also possible that
additional Fhits_ (as in classical insertional activation
induced by most oncogenic retroviruses) are necessary for
cells to be transformed and OPA to develop in the absence
of an infection with high virus dose; however, there is little
evidence for this event (Cousens et al., 2004).
Our study offers an additional interpretation. It appears
that JSRV can infect lymphoid cells/organs of the host
Fig. 5. Proposed models of naturally-occurring and experimentally induced
JSRV infection. We advance the hypothesis that infection of the cells target
for transformation is not the most common outcome of naturally-occurring
JSRV-infection. Cells of the lymphoreticular system are the main reservoir
of JSRV infection. Only in a small proportion of naturally infected sheep,
JSRV is able to infect type II pneumocytes/Clara cells and induce lung
adenocarcinoma. On the contrary, lambs are experimentally inoculated with
high virus doses intratracheally and develop almost constantly lung
adenocarcinoma as a result of direct infection of type II pneumocytes/
Clara cells.
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transformation. Thus, the infection of lung cells, in a
naturally infected animal, might be in many instances
secondary to infection of cells of the lymphoreticular
system or not happening at all.
Type II pneumocytes/Clara cells are stable cells with a
very low replicative index in adults unless injury to the
epithelium occurs (Mason and Shannon, 1997; Plopper et
al., 1997). Retroviruses in general (with the exception of
lentiviruses) are able to infect only cells in active mitosis
because of the impossibility of the viral pre-integration
complex to pass through an intact nuclear membrane
(Brown, 1997). We believe that lymphoid cells/macro-
phages of an adult sheep are initially infected by JSRV and
the virus will then be able to infect the target cells for
transformation only if a Fwindow of opportunity_ induced
by secondary stimuli allows division of type II pneumo-
cytes/Clara cells. Bacterial pneumonias and parasitic infes-
tations for example are a common observation in naturally
occurring OPA and they are always referred as Fsecondary_
infections that are favoured by alterations of the lung
microenvironment induced by the OPA tumour. We believe
that the opposite scenario might also occur. It might be the
case that bacterial infections (or anything causing lung
epithelium micro injuries) might induce the optimal
conditions for the infection of lung cells by JSRV. Maedi-
Visna and OPA also often co-exist in the same animal
(Dawson et al., 1990; Rosadio et al., 1988; Snyder et al.,
1983) and might have a similar Fsynergistic_ effect.
The above interpretation on the pathogenesis of OPA
reconciles the differences observed in the incubation period
between experimental and natural OPA (Fig. 5). The long
incubation period of naturally occurring OPA could mainly
be due to the length of the period between infection by
JSRV of lymphoid cells/macrophages and infection of the
target cells for transformation. Experimentally, lambs are
inoculated intratracheally with high amounts of virus;
therefore, JSRV can directly infect type II pneumocytes/
Clara cells. In addition, type II pneumocytes/Clara cells
have likely a higher mitotic index in lambs due to the
growth of the organ. In general, young animals might be
more susceptible of having type II pneumocytes/Clara cells
infected by JSRV and develop tumours subsequently.
Experimentally, there is a correlation between incubation
period and age of the experimentally inoculated lambs
(DeMartini et al., 1987; Salvatori et al., 2004). Thus, the
period between infection of lung cells and their trans-
formation is likely the same in the naturally and exper-
imentally-induced OPA. Onset of clinical signs might still
occur more rapidly in the experimentally inoculated lambs
because they are infected with high virus doses and more
cells would presumably be transformed at the same time.
The Fwindow of opportunity_ hypothesis conforms with
general constraints of virus evolution. One might predict
that a replication competent virus with a structural protein
functioning as powerful oncogene would not be successfulin evolutionary terms. The fact that JSRV can infect cells in
which viral expression is relatively restricted (and con-
sequently are not susceptible to transformation) might be a
way to assure maintenance of the virus in the host and
possibly in the population. However, when an occasional
Fwindow of opportunity_ presents itself, JSRV might infect
and transform type II pneumocytes/Clara cells. In this case,
the tumour in an OPA-affected sheep might function as an
amplifier of infection, which would benefit virus survival in
the population because the neoplastic cells are the only cells
known to allow abundant production of JSRV.
As mentioned above, it is possible to detect JSRV
antigens in adult sheep only in the tumour cells themselves
and not in the neighbouring untransformed type II pneumo-
cytes/Clara cells, both in advanced (Palmarini et al., 1995;
Platt et al., 2002) or early lesions as shown in this study.
Thus, type II pneumocytes/Clara cells just outside the
tumour are not infected despite the fact that there is an
abundant local production of infectious JSRV. This obser-
vation supports the hypothesis that the target cells for
transformation are normally not infectable. Another possi-
bility is that the target cells for transformation are not type II
pneumocytes/Clara cells but rather less numerous common
precursors of the type II pneumocytes/Clara Cells lineage
(Marchevsky, 1990; Stripp et al., 1995).
The main difficulties faced by studies on natural trans-
mission of JSRV are due to the lack of a detectable immune
response of sheep against JSRV infection, and the very low
proviral burden present in PBLs of naturally infected sheep.
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estimated and experimentally observed sensitivity of only
around 17% with a single test on PBLs DNA. Because
repeated testing would necessarily decrease the specificity
of the PCR assay, in the present study, we employed
approximately 800 intercalated DNA extraction and PCR
controls to monitor PCR contaminations in the samples of
the animals of Groups A, AB and B. Therefore, we are
confident in the definition of a JSRV-infected animal as an
animal that had at least one positive JSRV PCR test. Indeed,
in the three animals that presented clinical symptoms of
OPA (sheep number 7) or histopathological lesions with no
clinical signs (sheep numbers 3 and 31) only 2/9, 3/12 and
1/11 of PBLs and lymphoid organs tested positive during
the course of this study. Thus, it is not surprising that three
animals of the 29 of the Group B were positive for JSRV by
PCR with one of them showing OPA neoplastic lesions. In
the light of the data shown in this study, we could not have
constituted an OPA-free group of sheep by choosing only
sheep from flocks with no recent history of OPA, even with
two subsequent negative PCR tests. It is therefore likely
(certain for sheep no. 31) that those three animals were
indeed infected with JSRV rather than being false positives.
In any case, the three sheep of Group B that tested JSRV
positive did not influence the statistical significance of the
results obtained by comparing the level of JSRV infection
between animals of Groups A, B and AB.
This study has not yet clarified the means of transmission
for JSRV in nature, whether a JSRV-infected animal without
neoplastic lesions is able to transmit infection, and if sheep
with clinical disease are necessary to maintain virus survival
in the population. Sheep were housed together in an indoor
pen with free outdoor access during this study. Conse-
quently, the spread of infection has been likely facilitated
with respect to sheep kept in commercial flocks although
indoor housing during winter/lambing is becoming increas-
ingly common procedure in some sheep-rearing countries.
The adult ewes constituting Group A were collected from a
commercial flock where we estimated an incidence of
infection around 35% which is higher than previously
thought. Epidemiological studies in natural settings will be
necessary to further understand the transmission and patho-
genesis of JSRV infection and OPA.Materials and methods
Animals
Animals were kept in accordance with regulations and
approval of the Italian Ministry of Health. A commercial
flock composed by 220 sheep with approximately 3%
annual mortality due to OPA was tested for the presence of
JSRV infection by PCR on DNA derived from peripheral
blood leucocytes (see below). Fourteen ewes of the
Appenninica (n = 4), Sarda (n = 1) breed or Appenninica-Sarda cross (n = 10) that tested PCR positive to JSRV where
purchased and transported to the animal facilities of the
Istituto Zooprofilattico degli Abruzzi e Molise where they
were designated animals of Group A (JSRV-infected
animals) and were kept in an indoor/outdoor pen. At time
0 of the experiment, all the animals were between 4 and 5
years old. One sheep of Group A died at the beginning of
the study for reasons unrelated to OPA and was not part of
our analysis. Animals of Group B (n = 22) were obtained
from a flock of the Institute Zooprofilattico degli Abruzzi
with no recent history of OPA and were kept in separate
accommodation. Animals were of Appenninica-sarda cross
and were 6 years old on average. Immediately after the
establishment of Group B, 6 animals were chosen at random
and housed with animals of Group A, constituting Group
AB. Oestrus cycles of the ewes were synchronised and
animals were mated to rams that were previously negative
for JSRV hnLTR-PCR (see below). Different rams were
used for the various groups. At the completion of the
experiment (or at the onset of clinical signs for sheep
number 7), animals were euthanised and samples of lungs,
mediastinal lymph nodes and spleen were flash frozen and
stored at 80 -C. Tissue samples were excised using
individual sterile instruments for each sample. Lungs were
inspected for macroscopic lesions. For most of the lungs
examined (46 out of 56), tissue samples derived from seven
anatomical regions (cranial part of left cranial lobe, caudal
part of left cranial lobe, left diaphragmatic lobe, right
diaphragmatic lobe, right middle lobe, right cranial lobe,
accessory lobe) were excised from the organ and cut into
two portions; one was snap frozen and stored at 80 -C,
while the other was fixed in formalin for subsequent
histopathological and immunohistochemical examination.
Samples of mediastinal lymph nodes and spleen were snap
frozen and stored at 80 -C.
All the animals employed in this study were tested and
resulted negative for Maedi-Visna, ovine mycoplasma and
Chlamydia ovis infections.
Virus detection
JSRV provirus was detected in peripheral blood leuco-
cytes (PBLs) and tissue samples by hemi-nested LTR PCR
(hnLTR-PCR) as previously described (Gonzalez et al.,
2001; Palmarini et al., 1996b). DNA was extracted from
PBLs and tissues using the DNAeasy Tissue Kit (Qiagen) as
described by the manufacturer. Given the low amount of
JSRV proviral DNA in PBLs of pre-clinical cases (De las
Heras et al., in press; Gonzalez et al., 2001; Holland et al.,
1999; Palmarini et al., 1996b), each sample was tested in
triplicate (500 ng of genomic DNA per aliquot) and the
reactions were considered positive when at least one of the
replicates was found to be positive. Given the high level of
sensitivity of the PCR test employed [1–10 copies of
plasmid target in 500 ng of genomic DNA (Holland et al.,
1999; Palmarini et al., 1996b)] great care was taken to
M. Caporale et al. / Virology 338 (2005) 144–153152avoid, and control for, PCR contamination. We used four
separate locations for DNA extractions, PCR mixture
preparation, sample addition and gel analysis. In addition,
we included controls for DNA extraction (blood from sheep
no. 28 from Group B or salmon sperm DNA) in all DNA
extraction procedures performed in this study. DNA from
the same controls was also tested in the PCR reaction itself.
We tested one intercalated DNA control for each sample of
PBLs, lymph node or spleen. In addition, we tested one
DNA control sample per each lung tested (e.g., one control
per seven lung aliquots). Thus, we tested a total of 1106
samples and 835 extractions and DNA controls not
including the common reaction mixture controls included
in each PCR reaction.
Statistical analysis
Data analyses were based on the following Fcase_
definition: an animal from an infected flock (e.g., belonging
to Group A) with at least one positive PCR result in blood or
organs, or an animal from a flock without any history of
OPA (e.g., belonging to Group B) and with OPA lesions
confirmed by histological and immunohistochemical exami-
nation. FControl_ animals were defined as animals from a
flock without any history of OPA (e.g., belonging to Group
B) and without any OPA immunohistological lesion.
Bayesian 95% credibility intervals for the sensitivity and
specificity values were estimated using an uninformed
uniform prior, a binomial likelihood function and a posterior
beta distribution (Sivia, 1996). The sensitivity and specific-
ity of the entire diagnostic process, based on repeated PCR
testing of each animal, were estimated using a Monte Carlo
simulation model running 5000 iterations in an @Risk
environment (Vose, 2000). The difference in the number of
positive animals by groups was evaluated by Fisher exact
probability test. Since 3 groups of animals were compared to
each other, the Bonferroni adjustment has been used for the
control of the type I error in multiple tests (Bland and
Altman, 1995). Therefore, the thresholds for statistical
significance in each Fisher’s test have been adjusted to
0.01667 and 0.0033 to provide in 3 tests an alpha level
overall of 0.05 and 0.01, respectively. The choice to use the
Bonferroni adjustment is based on the consideration that
adjustments are appropriate when the same test is repeated
in many sub-samples, as in our case (Perneger, 1998). The
number of positive PCR reactions obtained in PBLs,
lymphoid organs and lungs were compared using the chi-
squared test. The probability of infection of each single
animal (i.e., predictive value of the entire diagnostic process
performed on the animal during the entire experiment) has
been calculated using Bayes’ theorem (Martin et al., 1986).
Histopathology and immunohistochemistry
4–6 Am lung sections were stained with haematoxylin
and eosin and examined by light microscopy for tumourlesions. For most of the lungs (46 of 56), sections were taken
from paraffin blocks of tissues collected from 7 anatomically
distinct regions. Sections were also examined by immuno-
histochemistry for the presence of JSRV Gag and Env as
described previously (Palmarini et al., 1995; Salvatori et al.,
2004) except that an antigen retrieval step was included
before inhibiting endogenous peroxidase. The antigen
retrieval was performed by microwaving the sections in
10 mM citrate buffer (pH 6.00) at 800 W for 2  5 min.
OPA tumour tissue was used as a positive control.Acknowledgments
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